HomeRUBICON • NSE
add
Rubicon Research Ltd
Previous close
₹787.15
Day range
₹782.00 - ₹801.60
Year range
₹570.75 - ₹822.00
Market cap
129.82B INR
Avg Volume
220.04K
P/E ratio
60.30
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 4.76B | 51.73% |
Operating expense | 2.22B | 43.88% |
Net income | 727.97M | 91.20% |
Net profit margin | 15.31 | 26.01% |
Earnings per share | 4.41 | — |
EBITDA | 1.12B | 70.15% |
Effective tax rate | 19.64% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.51B | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 6.47B | — |
Shares outstanding | 163.22M | — |
Price to book | 18.76 | — |
Return on assets | — | — |
Return on capital | 19.87% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 727.97M | 91.20% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Rubicon Research is an Indian pharmaceutical company located in Mumbai.
The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
Founded
1999
Website
Employees
1,141
